JFL Life Sciences Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: JFLLIFE | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on JFL Life Sciences

M-Cap below 100cr DeciZen not available

JFL Life Sciences stock performance -

mw4me loader
P/E Ratio (SA):
15.40
Market Cap:
43.3 Cr.
52-wk low:
0
52-wk high:
0

Is JFL Life Sciences Ltd an attractive stock to invest in?

1. Is JFL Life Sciences Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that JFL Life Sciences Ltd is a below average quality company.

2. Is JFL Life Sciences Ltd undervalued or overvalued?

The key valuation ratios of JFL Life Sciences Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is JFL Life Sciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of JFL Life Sciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of JFL Life Sciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
JFL Life Sciences Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 6.1%8.4%7.3%16.7%11.4%-
Value Creation
Index
-0.6-0.4-0.50.2-0.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 31.830.232.833.642.843
Sales YoY Gr.--5.1%8.6%2.5%27.5%-
Adj EPS 0.60.70.83.52.62.6
YoY Gr.-20%25.8%318.1%-26.5%-
BVPS (₹) 9.19.810.614.129.329.3
Adj Net
Profit
0.30.40.52.82.83
Cash Flow from Ops. -33.2-5.92.3-9.1-
Debt/CF from Ops. -2.82.9-2.96.8-0.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA12.4%27.5%
Adj EPS NANA56.9%-26.5%
BVPSNANA44.2%108.4%
Share Price - - - 20.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
66.98.830.612.98.7
Op. Profit
Mgn %
4.26.26.6169.2NAN
Net Profit
Mgn %
11.21.68.36.66.6
Debt to
Equity
1.71.72.51.40.2-
Working Cap
Days
01972313453540
Cash Conv.
Cycle
01031081721810

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 12.39%

Net Profit is growing at healthy rate in last 3 years 56.92%

Debt to equity has declined versus last 3 years average to 0.22

Return on Equity has declined versus last 3 years average to 8.70%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - JFL Life Sciences Ltd.

Standalone Consolidated
TTM EPS (₹) 2.6 -
TTM Sales (₹ Cr.) 42.8 -
BVPS (₹.) 29.3 -
Reserves (₹ Cr.) 21 -
P/BV 1.34 -
PE 15.40 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 43.3
Equity (₹ Cr.) 11
Face Value (₹) 10
Industry PE 48.2

Management X-Ray of JFL Life Sciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of JFL Life Sciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23
Sales31.7830.1732.7733.5942.83
Operating Expenses 30.4628.3130.6128.2338.90
Manufacturing Costs0.180.300.190.300.34
Material Costs29.1326.4628.9125.8034.65
Employee Cost 0.961.250.981.431.83
Other Costs 0.190.310.530.702.08
Operating Profit 1.321.862.165.363.93
Operating Profit Margin (%) 4.2%6.2%6.6%16.0%9.2%
Other Income 00.030.090.891.64
Interest 0.751.161.232.081.42
Depreciation 0.150.240.280.370.43
Exceptional Items 00000
Profit Before Tax 0.420.500.753.803.72
Tax 0.120.140.200.990.91
Profit After Tax 0.300.360.542.812.81
PAT Margin (%) 1.0%1.2%1.7%8.4%6.6%
Adjusted EPS (₹)0.60.70.83.52.6
Dividend Payout Ratio (%)0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 5.015.386.8711.2932.27
Share Capital 0.420.420.508.0211
Reserves 4.594.956.383.2721.27
Minority Interest00000
Debt6.937.6413.6013.797.18
Long Term Debt2.901.318.188.411.39
Short Term Debt4.046.335.425.385.79
Trade Payables1.428.824.5715.447.39
Others Liabilities 2.782.493.967.742.22
Total Liabilities 16.1524.3329.0148.2649.06

Fixed Assets

Gross Block3.256.067.798.838.92
Accumulated Depreciation0.771.011.281.702.12
Net Fixed Assets2.485.056.507.136.80
CWIP 0.040000
Investments 00000
Inventories1.713.755.7414.9612.72
Trade Receivables9.6612.6611.8119.8022.47
Cash Equivalents 0.030.300.040.190.06
Others Assets2.242.564.936.187.01
Total Assets 16.1524.3329.0148.2649.06

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity -33.21-5.872.32-9.06
PBT 0.420.500.753.803.72
Adjustment 0.801.331.412.441.87
Changes in Working Capital -4.211.47-7.93-4.05-13.65
Tax Paid -0.01-0.08-0.090.13-1
Cash Flow From Investing Activity -0.61-2.76-1.64-0.710.86
Capex -0.61-2.78-1.72-1.690.24
Net Investments 0000.880.62
Others 00.020.080.100
Cash Flow From Financing Activity 3.61-0.197.25-1.468.07
Net Proceeds from Shares 0.7000.961.5618.16
Net Proceeds from Borrowing 0000.23-7.02
Interest Paid -0.63-1.10-1.20-2.08-1.42
Dividend Paid 00000
Others 3.540.927.49-1.17-1.65
Net Cash Flow 00.27-0.260.15-0.13
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)6.036.948.8530.9412.9
ROCE (%)8.7111.810.3223.1415.44
Asset Turnover Ratio1.971.491.230.870.88
PAT to CFO Conversion(x)-108.92-10.870.83-3.22
Working Capital Days
Receivable Days111135136172180
Inventory Days203353112118
Payable Days187185142120

JFL Life Sciences Ltd Stock News

JFL Life Sciences Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of JFL Life Sciences on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of JFL Life Sciences stood at ₹43.28.
The latest P/E ratio of JFL Life Sciences as of 01-Jan-1970 05:30 is 15.40.
The latest P/B ratio of JFL Life Sciences as of 01-Jan-1970 05:30 is 1.34.
The 52-week high of JFL Life Sciences is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of JFL Life Sciences is ₹42.83 ( Cr.) .

About JFL Life Sciences Ltd

The Company was incorporated as ‘JFL Life Sciences Private Limited’ on April 25, 2010 as a private limited company under the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Pursuant to a special resolution of company’s Shareholders passed in the extra-ordinary general meeting held on February 10, 2022, the Company was converted from a private limited company to public limited company and consequently, the name of the Company was changed to ‘JFL Life Sciences Limited’, and a fresh certificate of incorporation dated March 3, 2022 was issued to the Company by the Registrar of Companies, Gujarat at Ahmedabad.

Headquartered in Ahmedabad, Gujarat, JFL Life Sciences is engaged in the business of manufacturing of pharmaceutical products. The company is engaged in domestic as well as international business. With market presence in PAN India, products of JFL is supplied to 10 developed and developing countries throughout the World. To maintain its competitiveness and to further the cause of health care JFL has laid a strong R&D foundation and a FDA approved state of the art manufacturing facility near Ahmedabad. It is a manufacturing company, so its sales strategy is to sell its products in bulk to pharmaceuticals marketers and traders who in turn provide the channel for sales to customers. It does not sell it under any brand name and it use the same strategy for both domestic & international market. The company exports its products majorly to African countries, Middle Eastern countries and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing of a particular product. Few of its products are also registered with Ukraine, Uzbekistan, Kazakhstan (CIS countries) through merchants.

Business area of the company

JFL Life Sciences manufactures a wide range of pharmaceutical formulations. The company’s major products types are Dry powder injections; Tablets & Capsules (B-Lactam) solid oral dosage form; Tablet and capsules (General); and Oral Rehydration Solutions (ORS).

Major Events and Milestones

  • 2010: The company was incorporated as a private limited company under the name JFL Life Sciences Private Limited.
  • 2022: The company was converted from a private limited company to a public limited company and its name was changed to JFL Life Sciences Limited.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.